Hyperfine (NASDAQ:HYPR) Upgraded to “Hold” at Wall Street Zen

Hyperfine (NASDAQ:HYPR) was upgraded by equities researchers at Wall Street Zen from a “sell” rating to a “hold” rating in a research report issued on Saturday.

Several other brokerages also recently commented on HYPR. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Hyperfine in a research note on Wednesday, October 8th. Lake Street Capital lifted their target price on shares of Hyperfine from $1.50 to $2.00 and gave the stock a “buy” rating in a research note on Thursday, August 14th. Finally, Wells Fargo & Company lifted their target price on shares of Hyperfine from $0.68 to $0.85 and gave the stock an “equal weight” rating in a research note on Friday, August 15th. Two equities research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the stock has an average rating of “Hold” and an average price target of $1.28.

Hyperfine Stock Performance

HYPR stock opened at $1.28 on Friday. The company has a market capitalization of $100.58 million, a PE ratio of -2.46 and a beta of 1.10. Hyperfine has a one year low of $0.53 and a one year high of $2.22. The company’s 50 day moving average price is $1.42 and its two-hundred day moving average price is $1.02.

Hyperfine (NASDAQ:HYPR) last posted its quarterly earnings results on Wednesday, August 13th. The company reported ($0.12) EPS for the quarter, hitting the consensus estimate of ($0.12). The firm had revenue of $2.70 million for the quarter, compared to the consensus estimate of $3.00 million. Hyperfine had a negative net margin of 364.54% and a negative return on equity of 84.82%. Hyperfine has set its FY 2025 guidance at EPS. On average, research analysts predict that Hyperfine will post -0.57 EPS for the current year.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in Hyperfine stock. AMH Equity Ltd acquired a new stake in shares of Hyperfine, Inc. (NASDAQ:HYPR) during the first quarter, according to its most recent Form 13F filing with the SEC. The fund acquired 125,084 shares of the company’s stock, valued at approximately $90,000. AMH Equity Ltd owned 0.16% of Hyperfine at the end of the most recent quarter. 15.03% of the stock is owned by hedge funds and other institutional investors.

Hyperfine Company Profile

Hyperfine, Inc, a medical device company, provides magnetic resonance imaging (MRI) products in the United States. The company offers Swoop Portable MR imaging system, which offers portable brain neuroimaging; and support and technical assistance services. It serves ICU, comprehensive, and primary stroke accredited facilities through direct sales and distributors.